|

Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

NOT_RECRUITINGPhase 2Sponsored by Dogwood Therapeutics Inc.
No longer actively recruiting
PhasePhase 2
SponsorDogwood Therapeutics Inc.
Started2025-02-21
Est. completion2026-07
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations25 sites
View on ClinicalTrials.gov →

NCT06848348

Summary

A randomized study to determine safety and efficacy of a series of subcutaneous (SC) injections of HAL in patients with CINP, compared to matching placebo injections. After that, subjects may have the option to enter an Open Label extension phase, where available, in which all subjects will receive Halneuron.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Male or female patients aged ≥18 years.
* Neuropathic pain has been present and is attributed to platinum and/or taxane chemotherapy.
* Patient has received a cancer chemotherapy regimen that included taxanes and/or platinum and has no active or discernible disease progression.

Exclusion Criteria:

* Current neuropathic pain with symptoms similar to CINP but attributed to causes other than platinum or taxane chemotherapy.
* Patients who have received HAL at any time prior to screening.

Conditions5

Breast CancerCancerChemotherapy Induced Neuropathic PainChemotherapy Induced PainChemotherapy Induced Pain Neuropathy

Interventions2

HalneuronHalneuron (Open Label Extension)

Locations25 sites

Central Recruiting Site
Sheffield, Alabama, 35660
Central Recruiting Site
Glendale, Arizona, 85308
Central Recruiting Site
Phoenix, Arizona, 85022
Central Recruiting Site
Fair Oaks, California, 95628
Central Recruiting Site
Fountain Valley, California, 92708

Find trials near these locations

All trials in ArizonaAll trials in CaliforniaAll trials in ColoradoAll trials in FloridaAll trials in IllinoisAll trials in LouisianaAll trials in MissouriAll trials in NevadaAll trials in New YorkAll trials in North CarolinaAll trials in TexasAll trials in Wisconsin

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.